D. Boral Capital Lowers Quince Therapeutics (NASDAQ:QNCX) Price Target to $4.00
Quince Therapeutics (NASDAQ:QNCX – Free Report) had its target price cut by D. Boral Capital from $12.00 to $4.00 in a research report report published on Tuesday morning,Benzinga reports. They currently have a buy rating on the stock. Other analysts also recently issued research reports about the company. Brookline Capital Management initiated coverage on Quince […]
Quince Therapeutics (NASDAQ:QNCX – Free Report) had its target price cut by D. Boral Capital from $12.00 to $4.00 in a research report report published on Tuesday morning,Benzinga reports. They currently have a buy rating on the stock. Other analysts also recently issued research reports about the company. Brookline Capital Management initiated coverage on Quince […]
